Literature DB >> 11123098

Osteoarthritis and cartilage: the role of cytokines.

M B Goldring1.   

Abstract

The pathogenesis of osteoarthritis involves multiple etiologies, including mechanical, biochemical, and genetic factors that contribute to the imbalance in the synthesis and destruction of articular cartilage. It is now well documented that interleukin-1 and tumor necrosis factor-alpha are the predominant proinflammatory and catabolic cytokines involved in disease initiation and progression. Other proinflammatory cytokines may amplify or modulate this process, whereas anti-inflammatory cytokines, which are often detected, paradoxically, in osteoarthritis tissues, may counteract the tissue destruction and inflammation. This review focuses on the role of cytokines in the pathogenesis of osteoarthritis with special emphasis on how findings in culture and animal models may be reflected in the human disease process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123098     DOI: 10.1007/s11926-000-0021-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

Review 1.  New targets for anti-inflammatory drugs.

Authors:  A J Lewis; A M Manning
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

Review 2.  Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Authors:  P Garnero; J C Rousseau; P D Delmas
Journal:  Arthritis Rheum       Date:  2000-05

Review 3.  Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses.

Authors:  A Baici
Journal:  Biol Chem       Date:  1998 Aug-Sep       Impact factor: 3.915

4.  The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.

Authors:  H Okamoto; M Yamamura; Y Morita; S Harada; H Makino; Z Ota
Journal:  Arthritis Rheum       Date:  1997-06

Review 5.  Degradative enzymes in osteoarthritis.

Authors:  R L Smith
Journal:  Front Biosci       Date:  1999-10-15

6.  Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.

Authors:  E Lubberts; L A Joosten; L van Den Bersselaar; M M Helsen; A C Bakker; J B van Meurs; F L Graham; C D Richards; W B van Den Berg
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

Review 7.  Cytokines in osteoarthritis: mediators or markers of joint destruction?

Authors:  C I Westacott; M Sharif
Journal:  Semin Arthritis Rheum       Date:  1996-02       Impact factor: 5.532

8.  The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.

Authors:  J U Yoo; T S Barthel; K Nishimura; L Solchaga; A I Caplan; V M Goldberg; B Johnstone
Journal:  J Bone Joint Surg Am       Date:  1998-12       Impact factor: 5.284

9.  Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.

Authors:  E Lubberts; L A Joosten; M M Helsen; W B van den Berg
Journal:  Cytokine       Date:  1998-05       Impact factor: 3.861

10.  Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB.

Authors:  T Shalom-Barak; J Quach; M Lotz
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

View more
  149 in total

1.  A painful interface between normal aging and disease.

Authors:  Shari Miura Ling; Eleanor M Simonsick; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-06       Impact factor: 6.053

Review 2.  [Degenerative DNA alterations in osteoarthritis].

Authors:  S Söder
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

3.  Serum and synovial fluid C-reactive protein level variations in dogs with degenerative joint disease and their relationships with physiological parameters.

Authors:  S Boal; L Miguel Carreira
Journal:  Vet Res Commun       Date:  2015-07-16       Impact factor: 2.459

Review 4.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 5.  Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes.

Authors:  Mingcai Zhang; Brian Egan; Jinxi Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-05-12       Impact factor: 5.085

6.  Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13).

Authors:  Zhigang Li; Baoyi Liu; Dewei Zhao; BenJie Wang; Yupeng Liu; Yao Zhang; Fengde Tian; Borui Li
Journal:  Cell Stress Chaperones       Date:  2017-05-17       Impact factor: 3.667

7.  The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone.

Authors:  K Takebe; M F Rai; E J Schmidt; L J Sandell
Journal:  Osteoarthritis Cartilage       Date:  2014-12-09       Impact factor: 6.576

8.  Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation.

Authors:  Amy L McNulty; Nicole E Rothfusz; Holly A Leddy; Farshid Guilak
Journal:  J Orthop Res       Date:  2013-03-11       Impact factor: 3.494

9.  Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee.

Authors:  S D Chua; S P Messier; C Legault; M E Lenz; E J-M A Thonar; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2008-03-24       Impact factor: 6.576

10.  The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale.

Authors:  Stephen P Messier; Claudine Legault; Shannon Mihalko; Gary D Miller; Richard F Loeser; Paul DeVita; Mary Lyles; Felix Eckstein; David J Hunter; Jeff D Williamson; Barbara J Nicklas
Journal:  BMC Musculoskelet Disord       Date:  2009-07-28       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.